Related Experiment Videos
Evaluation of biomatrix hydroxyapatite ocular implants with technetium-99m-MDP
D Baumgarten1, T Wojno, A Taylor
1Department of Radiology, Emory University School of Medicine, Atlanta, Georgia.
Summary
Hydroxyapatite ocular implants offer good cosmetic results with fewer complications. Technetium-99m-methylene diphosphonate (MDP) scintigraphy noninvasively confirms implant vascularization, enabling timely prosthetic eye attachment.
Area of Science:
- Ophthalmology
- Nuclear Medicine
- Biomaterials Science
Background:
- Hydroxyapatite implants are increasingly used for ocular prosthetics due to superior cosmetic outcomes and reduced infection/extrusion rates compared to traditional implants.
- Successful integration of a hydroxyapatite ocular implant requires adequate vascularization to support the prosthetic eye.
- Assessing implant vascularity is crucial before proceeding with the attachment of the artificial eye.
Observation:
- Technetium-99m-methylene diphosphonate (99mTc-MDP) scintigraphy presents a noninvasive imaging technique to evaluate the vascularity of hydroxyapatite ocular implants.
- A specific case demonstrated the utility of 99mTc-MDP scintigraphy in assessing implant vascularization.
Findings:
- The 99mTc-MDP scintigraphy revealed sufficient uptake within the hydroxyapatite implant in the presented case.
- This uptake indicated adequate vascularization necessary for the next surgical stage.
Implications:
- 99mTc-MDP scintigraphy is a valuable tool for determining the readiness of hydroxyapatite ocular implants for prosthetic eye attachment.
- This noninvasive method can optimize surgical planning and potentially improve patient outcomes in ocular reconstruction.
- Further studies could explore the standardization of 99mTc-MDP uptake criteria for hydroxyapatite ocular implants.